Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

AVITA Medical (RCEL) Receivables - Net (2018 - 2025)

AVITA Medical's Receivables - Net history spans 8 years, with the latest figure at $9.1 million for Q4 2025.

  • For Q4 2025, Receivables - Net fell 22.91% year-over-year to $9.1 million; the TTM value through Dec 2025 reached $9.1 million, down 22.91%, while the annual FY2025 figure was $9.1 million, 22.91% down from the prior year.
  • Receivables - Net reached $9.1 million in Q4 2025 per RCEL's latest filing, up from $9.0 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $12.0 million in Q1 2025 to a low of $2.2 million in Q1 2021.
  • Average Receivables - Net over 5 years is $6.5 million, with a median of $5.8 million recorded in 2023.
  • Peak YoY movement for Receivables - Net: soared 118.04% in 2023, then fell 22.91% in 2025.
  • A 5-year view of Receivables - Net shows it stood at $3.1 million in 2021, then grew by 12.73% to $3.5 million in 2022, then surged by 118.04% to $7.7 million in 2023, then skyrocketed by 53.78% to $11.8 million in 2024, then dropped by 22.91% to $9.1 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Receivables - Net are $9.1 million (Q4 2025), $9.0 million (Q3 2025), and $11.3 million (Q2 2025).